Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

3 Undervalued Growth Stocks to Buy and Hold for the Long Term

By Larry Ramer, InvestorPlace Contributor

The tech slump should not last very long-so long-term investors should buy undervalued growth stocks at this point. 

Is Mullen Stock Too Risky to Touch?

By Larry Ramer, InvestorPlace Contributor

It's hard to put much faith in the organizations that have tested Mullen Automotive's batteries, making MULN stock a sell.

Robinhood (HOOD) Stock Hits a New All-Time Low

By Larry Ramer, InvestorPlace Contributor

Robinhood's market capitalization is now below the value of its cash, and two research firms are bearish on HOOD stock.

Revlon Is Bankrupt. What Comes Next for REV Stock?

By Larry Ramer, InvestorPlace Contributor

Revlon is seeking bankruptcy protection as the company has been unable to overcome multiple problems. REV stock may become worthless.

Novavax Stock Can Rally, But It’s Still Facing Many Obstacles

By Larry Ramer, InvestorPlace Contributor

Novavax's vaccine will likely be approved by the FDA relatively soon, but NVAX stock is still facing many obstacles.

Load More